Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Chemours (CC) EBT Margin (2016 - 2025)

Chemours (CC) has 12 years of EBT Margin data on record, last reported at 29.1% in Q4 2025.

  • For Q4 2025, EBT Margin rose 2902.0% year-over-year to 29.1%; the TTM value through Dec 2025 reached 2.41%, up 54.0%, while the annual FY2025 figure was 3.03%, 83.0% up from the prior year.
  • EBT Margin reached 29.1% in Q4 2025 per CC's latest filing, up from 2.54% in the prior quarter.
  • Across five years, EBT Margin topped out at 29.1% in Q4 2025 and bottomed at 26.08% in Q2 2023.
  • Average EBT Margin over 5 years is 1.41%, with a median of 2.6% recorded in 2021.
  • Peak YoY movement for EBT Margin: tumbled -3815bps in 2023, then soared 3052bps in 2024.
  • A 5-year view of EBT Margin shows it stood at 20.97% in 2021, then dropped by -2bps to 21.38% in 2022, then soared by 76bps to 5.03% in 2023, then skyrocketed by 101bps to 0.07% in 2024, then skyrocketed by 39444bps to 29.1% in 2025.
  • Per Business Quant database, its latest 3 readings for EBT Margin were 29.1% in Q4 2025, 2.54% in Q3 2025, and 16.84% in Q2 2025.